These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 3571423)

  • 1. Neuropeptide Y and its flanking peptide in human endocrine tumors and plasma.
    Allen JM; Yeats JC; Causon R; Brown MJ; Bloom SR
    J Clin Endocrinol Metab; 1987 Jun; 64(6):1199-204. PubMed ID: 3571423
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression and precursor processing of neuropeptide Y in human pheochromocytoma and neuroblastoma tumors.
    O'Hare MM; Schwartz TW
    Cancer Res; 1989 Dec; 49(24 Pt 1):7010-4. PubMed ID: 2582442
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Release of neuropeptide Y from pheochromocytomas.
    Takahashi K; Mouri T; Sone M; Murakami O; Itoi K; Ohneda M; Yoshinaga K
    Endocrinol Jpn; 1990 Feb; 37(1):53-60. PubMed ID: 2384052
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heterogeneity of neuropeptide Y immunoreactivity in patients with pheochromocytoma: influence on the diagnostic power of measuring plasma NPY using antisera with different specificities.
    Tabarin A; Cassiède P; Minot AP; Cuber JC; Roger P; Ducassou D
    Acta Endocrinol (Copenh); 1993 Mar; 128(3):243-50. PubMed ID: 8480474
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunolocalization of neuropeptide Y in human pancreatic endocrine tumors.
    Waeber G; Hurlimann J; Nicod P; Grouzmann E
    Peptides; 1995; 16(5):921-6. PubMed ID: 7479336
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuropeptide Y (NPY) and C-flanking peptide of NPY in the pineal gland of normal and ganglionectomized sheep.
    Cozzi B; Mikkelsen JD; Ravault JP; Møller M
    J Comp Neurol; 1992 Feb; 316(2):238-50. PubMed ID: 1349311
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma neuropeptide Y concentrations in patients with neuroendocrine tumors.
    Grouzmann E; Comoy E; Bohuon C
    J Clin Endocrinol Metab; 1989 Apr; 68(4):808-13. PubMed ID: 2466046
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression and precursor processing of neuropeptide Y in human and murine neuroblastoma and pheochromocytoma cell lines.
    O'Hare MM; Schwartz TW
    Cancer Res; 1989 Dec; 49(24 Pt 1):7015-9. PubMed ID: 2582443
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Production, characterization, and expression of neuropeptide Y by human pheochromocytoma.
    deS Senanayake P; Denker J; Bravo EL; Graham RM
    J Clin Invest; 1995 Nov; 96(5):2503-9. PubMed ID: 7593641
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The C-terminal flanking peptide of neuropeptide Y (NPY) is not essential for seizure-suppressant actions of prepro-NPY overexpression in male rats.
    Soud K; Jørgensen SH; Woldbye DPD; Sørensen AT
    J Neurosci Res; 2019 Mar; 97(3):362-372. PubMed ID: 30367522
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Localization of neuropeptide Y and its C-terminal flanking peptide in human renal tissue.
    Grouzmann E; Alvarez-Bolado G; Meyer C; Osterheld MC; Burnier M; Brunner HR; Waeber B
    Peptides; 1994; 15(8):1377-82. PubMed ID: 7700840
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Presence of the predicted C-flanking peptide of neuropeptide Y (CPON) in tissue extracts.
    Allen JM; Polak JM; Bloom SR
    Neuropeptides; 1985 Apr; 6(2):95-100. PubMed ID: 3839058
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuropeptide Y in neuroblastoma: increased concentration in metastasis, release during surgery, and characterization of plasma and tumor extracts.
    Kogner P; Björk O; Theodorsson E
    Med Pediatr Oncol; 1993; 21(5):317-22. PubMed ID: 8492745
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunohistochemical and chromatographic identification of peptides derived from proneuropeptide Y in the human frontal cortex.
    Mikkelsen JD; Larsen PJ; Kruse-Larsen C; O'Hare MM; Schwartz TW
    Brain Res Bull; 1993; 31(3-4):415-25. PubMed ID: 8490740
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Production of pituitary protein 7B2 immunoreactivity by endocrine tumors and its possible diagnostic value.
    Suzuki H; Ghatei MA; Williams SJ; Uttenthal LO; Facer P; Bishop AE; Polak JM; Bloom SR
    J Clin Endocrinol Metab; 1986 Sep; 63(3):758-65. PubMed ID: 3525602
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuropeptide-Y and Y-receptors in the autocrine-paracrine regulation of adrenal gland under physiological and pathophysiological conditions (Review).
    Spinazzi R; Andreis PG; Nussdorfer GG
    Int J Mol Med; 2005 Jan; 15(1):3-13. PubMed ID: 15583821
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radioimmunoassay for neuropeptide Y (NPY): chromatographic characterization of immunoreactivity in plasma and tissue extracts.
    Theodorsson-Norheim E; Hemsén A; Lundberg JM
    Scand J Clin Lab Invest; 1985 Jun; 45(4):355-65. PubMed ID: 3839315
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of messenger ribonucleic acids encoding neuropeptide-Y, substance-P, and vasoactive intestinal polypeptide in human pituitary.
    Byrne JM; Jones PM; Hill SF; Bennet WM; Ghatei MA; Bloom SR
    J Clin Endocrinol Metab; 1992 Oct; 75(4):983-7. PubMed ID: 1383256
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuropeptide Y in phaeochromocytomas and ganglioneuroblastomas.
    Adrian TE; Allen JM; Terenghi G; Bacarese-Hamilton AJ; Brown MJ; Polak JM; Bloom SR
    Lancet; 1983 Sep; 2(8349):540-2. PubMed ID: 6136694
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuropeptide Y- and somatostatin-like immunoreactivities in ganglioneuroma, ganglioneuroblastoma and neuroblastoma.
    Takahashi K; Mouri T; Itoi K; Sone M; Hayashi Y; Murakami O; Ohneda M; Ohi R; Yoshinaga K
    Endocrinol Jpn; 1989 Oct; 36(5):627-33. PubMed ID: 2620662
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.